Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment reporting

Analytics

N/A

1(33.3%)

Phase 3

1(33.3%)

Phase 4

1(33.3%)

3Total

N/A(1)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06624631Not ApplicableCompleted

PDMC Implementation Trial in Kenya

Role: collaborator

NCT06601712Phase 4Recruiting

Post-discharge Malaria Chemoprevention Implementation Trial in Benin

Role: lead

NCT03014167Phase 3Completed

Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH)

Role: collaborator

NCT06170320Completed

STREngthening COronavirus Disease 2019 (COVID-19) Surveillance in Africa

Role: collaborator

NCT05650502Completed

Impact of Seasonal Malaria Chemoprevention on Immunity Against Malaria Among Children in Northern Benin

Role: collaborator

NCT03780712Completed

Immune Dysfunction in Newborn Sepsis

Role: collaborator

All 6 trials loaded